Screening of Athletes

November 3, 2018 updated by: Prof. Dr. F. Staes, Universitaire Ziekenhuizen KU Leuven

Screening of Athletes for Prevention of Injury and Optimisation of Performance

Athletes have to participate in screenings in order to reduce injuries. Up-to-now most screenings are purely clinically based. Literature, however, indicates the importance of knowledge on deviant movement patterns as possible risk factors for injuries. From this perspective, the current project aims to measure movement patterns, gait and running in young athletes to optimise training and prevent injuries.

2D- and 3d registration methods, force plate data and pressure plate data will be used to document the performance of the athletes.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgium, 3000
        • KU Leuven/UZLeuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 22 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Athletes will be selected from a list offered by the Flemish Atlethics League. This incorporates a group of athletes with potential to become Elite Athletes of the highest international level

Description

Inclusion Criteria:

  1. Selected by the Flemish Athletics League
  2. Level: B1, B2 en C
  3. Age categories: 16-22 years
  4. No injuries at lower back and lower extremities in the past 6 months
  5. Signing informed consent

Exclusion Criteria:

  1. Not selected by the Flemish Athletics League
  2. Injuries at lower quadrant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
training advise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinematic and kinetic data
Time Frame: March - June 2014 (3 months)

Angles at different joints will be investigated with 3D movement analysis methods. Kinetic data (joint moments) will be calculated with 3D movement analysis methods.

Center of pressure measures will be calculated on the basis of force plate data.

Gait, running, jumps, postural balance will be investigated. Plantar pressure parameters will be calculated on the basis of plantar pressure measurements.

March - June 2014 (3 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2 D parameters
Time Frame: March - June 2014 (3 months)
Video analysis methods (Dartfish) will be used to calculate joint angles during jumps
March - June 2014 (3 months)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sports activities,personal demographics, injury history
Time Frame: March - June 2014 (3 months)
Sports activities, personal demographics and injury history will be documented through existing information from the medical department (Physical Rehabilitation of University Hospitals Leuven)
March - June 2014 (3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Filip F Staes, Professor, KU Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

February 4, 2014

First Submitted That Met QC Criteria

February 5, 2014

First Posted (Estimate)

February 6, 2014

Study Record Updates

Last Update Posted (Actual)

November 6, 2018

Last Update Submitted That Met QC Criteria

November 3, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • S56252

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Individual Differences

Clinical Trials on Advice

Subscribe